Back

Modeling MYH11-associated aortic disease using iPSC-derived vascular smooth muscle cells for gene therapy development

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Applied pathophysiology in aortic disease Aortic Aneurysm, Thoracic ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Aria Atash

University Medical Center Utrecht, Utrecht (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Cardiac interventions in Loeys-Dietz syndrome: insights into clinical management and outcomes
Doctor L. Dreher (Scottsdale, US)
Abstract Slides Video
Presentation thumbnail
Potential diagnostic biomarkers for aortic dissection in the emergency department: the Aggrecan, Desmosine, D-dimer - Emergency Department (ADD-ED) prospective observational study
Professor C. Graham (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Copy number variants in the genetic landscape of Hereditary Thoracic Aortic Disease (HTAD)
Doctor I. Cardenas Reyes (A Coruna, ES)
Abstract Slides Video
Presentation thumbnail
Lactate-mediated GATA6 degradation exacerbates thoracic aortic aneurysm/dissection through formation of proinflammatory vascular smooth muscle cells via annexin A1 pathway
Ms P. Pang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Residual dissection in the aortic arch branch vessels following type A aortic dissection surgery
Doctor J. Li (CN)
Abstract Slides Video

Access the full session

Session thumbnail
Applied pathophysiology in aortic disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
IPSC-derived vascular smooth muscle cell model recapitulates Loeys-Dietz-Syndrome type V aortic phenotype
thumbnail
Congress Presentation
In search of genetic modifiers that explain the phenotypic variability in SMAD3-related aortopathy
thumbnail
Congress Presentation
Exploring adventitial pericyte dysfunction and MEK/ERK signalling as therapeutic targets in thoracic aortic aneurysm

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources